Targeting the tyrosine kinase Src in endothelium attenuates inflammation and atherogenesis induced by disturbed flow
This article is part of a themed issue Drugs and Drug Targets in Metabolic and Chronic Inflammatory Diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v182.20/issuetoc.
Authors
- Minchun Jiang (ORCID: https://orcid.org/0000-0002-6726-7266)
- Xiaoqiang Yao (ORCID: https://orcid.org/0000-0002-0687-8186)
- Hanyi Ding (ORCID: https://orcid.org/0000-0002-0307-9119)
- Li Wang (ORCID: https://orcid.org/0000-0002-3377-8092)
- Ronald C.W. (ORCID: https://orcid.org/0000-0002-1227-803X)
- Yin Xia (ORCID: https://orcid.org/0000-0003-0315-7532)
- Andrew M. Chan (ORCID: https://orcid.org/0000-0001-9923-5464)
- Yü Huang (ORCID: https://orcid.org/0000-0002-1277-6784)
Institutions
- City University of Hong Kong (HK)
- Chinese University of Hong Kong (HK)
- Prince of Wales Hospital (CN)
Publication Details
- Journal
- British Journal of Pharmacology
- Published
- 2024-08-08
- DOI
- https://doi.org/10.1111/bph.17307
- Citations
- 11
- Primary Topic
- Angiogenesis and VEGF in Cancer
- Type
- article
- Field-Weighted Citation Impact
- 2.57
Funders
- National Natural Science Foundation of China
- Health and Medical Research Fund